Literature DB >> 1710888

Hypomethylation of the decorin proteoglycan gene in human colon cancer.

R Adany1, R V Iozzo.   

Abstract

We have previously reported that the connective tissue stroma of human colon carcinoma contains elevated amounts of decorin, a small proteoglycan involved in the regulation of matrix formation and cell proliferation. These biochemical changes were correlated with increased mRNA levels and general hypomethylation of the decorin gene in human colon cancer DNA. In this report we use a quantitative polymerase chain reaction method coupled with digestion of the DNA template by methylation-sensitive restriction endonucleases to investigate in detail the location of hypomethylated sites in decorin gene. We demonstrate that a specific site in the 3' region of the gene, encompassing codons 360-361, is specifically hypomethylated in both colon carcinoma and benign polyp. In contrast, three HpaII sites, clustered in the 5' untranslated region, show full methylation in normal and neoplastic DNA. The lack of such changes in ulcerative colitis DNA suggests that chronic inflammation alone is not sufficient to alter cytosine methylation in the decorin gene. These results suggest the possibility that the 3' region of the decorin-coding sequence may be involved in the control of decorin gene expression.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1710888      PMCID: PMC1151091          DOI: 10.1042/bj2760301

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  33 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction.

Authors:  K B Mullis; F A Faloona
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Primary structure of an extracellular matrix proteoglycan core protein deduced from cloned cDNA.

Authors:  T Krusius; E Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-10       Impact factor: 11.205

4.  Effect of regional DNA methylation on gene expression.

Authors:  I Keshet; J Yisraeli; H Cedar
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

Review 5.  Cell surface heparan sulfate proteoglycan and the neoplastic phenotype.

Authors:  R V Iozzo
Journal:  J Cell Biochem       Date:  1988-05       Impact factor: 4.429

6.  Altered methylation of versican proteoglycan gene in human colon carcinoma.

Authors:  R Adany; R V Iozzo
Journal:  Biochem Biophys Res Commun       Date:  1990-09-28       Impact factor: 3.575

7.  Dynamic state of site-specific DNA methylation concurrent to altered prolactin and growth hormone gene expression in the pituitary gland of pregnant and lactating rats.

Authors:  V Kumar; D K Biswas
Journal:  J Biol Chem       Date:  1988-09-05       Impact factor: 5.157

8.  Tissue-specific levels of human glucose-6-phosphate dehydrogenase correlate with methylation of specific sites at the 3' end of the gene.

Authors:  G Battistuzzi; M D'Urso; D Toniolo; G M Persico; L Luzzatto
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

Review 9.  Proteoglycans and neoplasia.

Authors:  R V Iozzo
Journal:  Cancer Metastasis Rev       Date:  1988-04       Impact factor: 9.264

10.  Neoplastic modulation of extracellular matrix. Colon carcinoma cells release polypeptides that alter proteoglycan metabolism in colon fibroblasts.

Authors:  R V Iozzo
Journal:  J Biol Chem       Date:  1985-06-25       Impact factor: 5.157

View more
  13 in total

1.  Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels.

Authors:  Simone Buraschi; Nutan Pal; Nadia Tyler-Rubinstein; Rick T Owens; Thomas Neill; Renato V Iozzo
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

Review 2.  DNA hypomethylation in the origin and pathogenesis of human diseases.

Authors:  Igor P Pogribny; Frederick A Beland
Journal:  Cell Mol Life Sci       Date:  2009-03-27       Impact factor: 9.261

3.  Decorin in Human Colon Cancer: Localization In Vivo and Effect on Cancer Cell Behavior In Vitro.

Authors:  Marie C Nyman; Annele O Sainio; Mirka M Pennanen; Riikka J Lund; Sanna Vuorikoski; Jari T T Sundström; Hannu T Järveläinen
Journal:  J Histochem Cytochem       Date:  2015-05-22       Impact factor: 2.479

4.  De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells.

Authors:  M Santra; T Skorski; B Calabretta; E C Lattime; R V Iozzo
Journal:  Proc Natl Acad Sci U S A       Date:  1995-07-18       Impact factor: 11.205

Review 5.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

6.  Exon-specific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine. Modulation by dietary folate.

Authors:  Y I Kim; I P Pogribny; R N Salomon; S W Choi; D E Smith; S J James; J B Mason
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

Review 7.  Decorin as a multivalent therapeutic agent against cancer.

Authors:  Thomas Neill; Liliana Schaefer; Renato V Iozzo
Journal:  Adv Drug Deliv Rev       Date:  2015-10-30       Impact factor: 15.470

Review 8.  Molecular characterisation of the tumour microenvironment in breast cancer.

Authors:  Min Hu; Kornelia Polyak
Journal:  Eur J Cancer       Date:  2008-11-19       Impact factor: 9.162

Review 9.  Altered proteoglycan gene expression and the tumor stroma.

Authors:  R V Iozzo; I Cohen
Journal:  Experientia       Date:  1993-05-15

10.  Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model.

Authors:  Simone Buraschi; Thomas Neill; Rick T Owens; Leonardo A Iniguez; George Purkins; Rajanikanth Vadigepalli; Barry Evans; Liliana Schaefer; Stephen C Peiper; Zi-Xuan Wang; Renato V Iozzo
Journal:  PLoS One       Date:  2012-09-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.